Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease

Biochemical Society Transactions

Volumn 39, Issue 5, 2011, Pages 1226-1232

  Winyard, Paul G ^a   Ryan, Brent ^a,c   Eggleton, Paul ^a   Nissim, Ahuva ^b   Taylor, Emma ^a   Lo Faro, Maria Letizia ^a   Burkholz, Torsten ^a   Szabó Taylor, Katalin E ^a   Fox, Bridget ^a   Viner, Nick ^a   Haigh, Richard C ^a   Benjamin, Nigel ^a   Jones, Andrew M ^a   Whiteman, Matthew ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Advanced glycation end product (AGE); Reactive nitrogen species (RNS); Reactive oxygen species (ROS); Reactive sulfur species (RSS); Rheumatoid arthritis (RA)

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; CYSTATHIONINE BETA LYASE; CYSTATHIONINE BETA SYNTHASE; GAMMA INTERFERON; HYDROGEN SULFIDE; INTERLEUKIN 1; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; PEROXYNITRITE; PROTEIN ARGININE DEIMINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REACTIVE SULFUR SPECIES; S NITROSOTHIOL; TUMOR NECROSIS FACTOR ALPHA;

ARTHROPATHY; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; BLOOD PRESSURE; CHEMOLUMINESCENCE; DISEASE ACTIVITY; DNA DAMAGE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INTRACELLULAR SIGNALING; MASS FRAGMENTOGRAPHY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

AMINO ACIDS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; EPITOPES; HUMANS; INFLAMMATION; NITRATES; NITRITES; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SPECTROPHOTOMETRY; SULFUR; SYNOVIAL FLUID;

EID: 80053360921     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391226     Document Type: Review

References (51)

1. Pattison, D. and Winyard, P.G. (2008) Antioxidants in rheumatoid arthritis: an overview. Nat. Rev. Rheumatol. 4, 590-596
2. Tarr, J.M., Winyard, P.G., Ryan, B., Harries, L.W., Haigh, R., Viner, N. and Eggleton, P. (2010) Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells. Arthritis Rheum. 62, 2919-2929
3. Jacob, C. and Winyard, P.G. (2009) Introduction. In Redox Signaling and Regulation in Biology and Medicine (Jacob, C. and Winyard, P.G., eds.), pp. 1-13, Wiley-VCH, Weinheim
4. Phillips, D.C., Dias, H.K., Kitas, G.D. and Griffiths, H.R. (2010) Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid. Redox Signaling 12, 743-785
5. Merry, P., Winyard, P.G., Morris, C.J., Grootveld, M. and Blake, D.R. (1989) Oxygen free radicals, inflammation, and synovitis: the current status. Ann. Rheum. Dis. 48l, 864-870
6. Winyard, P.G., Moody, C.J. and Jacob, C. (2005) Oxidative activation of antioxidant defence. Trends Biochem. Sci. 30, 453-461 (Pubitemid 41033241)
7. Brown, N.S. and Bicknell, R. (2001) Hypoxia and oxidative stress in breast cancer: oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3, 323-327 (Pubitemid 32851163)
8. Tak, P.P., Zvaifler, N.J., Green, D.R. and Firestein, G.S. (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseasesImmunol. Today 21, 78-82 (Pubitemid 30069620)
9. Bang, H., Egerer, K., Gauliard, A., Lüthke, K., Rudolph, P.E., Fredenhagen, G., Berg, W., Feist, E. and Burmester, G.-R. (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 56, 2503-2511 (Pubitemid 47237269)
10. Evans, M.D., Olinski, R., Loft, S. and Cooke, M.S. (2010) Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J. 24, 1249-1260
11. Bashir, S., Harris, G., Denman, M.A, Blake, D.R. and Winyard, P.G. (1993) Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52, 659-666 (Pubitemid 23280435)
12. Stadtman, E.R. and Levine, R.L. (2006) Protein oxidation. Ann. N.Y. Acad. Sci. 899, 191-208
13. Aldini, G., Dalle-Donne, I., Maffei, R., Aldo, F. and Carini, M.M. (2007) Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 27, 817-868 (Pubitemid 350035121)
14. Spickett, C.M. and Fauzi, N.M. (2011) Analysis of oxidized and chlorinated lipids by mass spectrometry and relevance to signalling. Biochem. Soc. Trans. 39, 1233-1239
15. Morgan, P.E., Sturgess, A.D. and Davies, M.J. (2009) Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radical Res. 43, 117-127
16. Scofield, R.H., Kurien, B.T., Ganick, S., McClain, M.T., Pye, Q., James, J.A., Schneider, R.I., Broyles, R.H., Bachmann, M. and Hensley, K. (2005) Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biol. Med. 38, 719-728 (Pubitemid 40249742)
17. Wang, G., Pierangeli, S.S., Papalardo, E., Ansari, G.A.S. and Khan, M.F. (2010) Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 62, 2064-2072
18. Amara, A., Constans, J., Chaugier, C., Sebban, A., Dubourg, L., Peuchant, E., Pellegrin, J.L., Leng, B., Conri, C. and Geffard, M. (1995) Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin. Exp. Immunol. 101, 233-238
19. Svenungsson, E., Jensen-Urstad, K., Heimburger, M., Silveira, A., Hamsten, A., De Faire, U., Witztum, J.L. and Frostegard, J. (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104, 1887-1893 (Pubitemid 32983229)
20. ε-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose. Biochem. J. 376, 109-121
21. Rodriguez-Garcia, J., Requena, J.R. and Rodriguez-Segade, S. (1998) Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin. Chem. 44, 250-255 (Pubitemid 28087720)
22. Ahmed, N., Ahmed, U., Thornalley, P.J., Watts, R., Tarr, J., Haigh, R. and Winyard, P.G. (2006) Profound increase in proteolytic products of glycated and oxidised proteins in synovial fluid and plasma in osteoarthritis and rheumatoid arthritis, corrected by TNF-antibody therapy in rheumatoid arthritis. Rheumatology 45 (Suppl. 1), i53
23. Lunec, J., Griffiths, H.R. and Brailsford, S. (1988) Oxygen free radicals denature human IgG and increase its reactivity with rheumatoid factor antibody. Scand. J. Rheumatol. 75, 140-147 (Pubitemid 19126209)
24. Ligier, S., Fortin, P.R. and Newkirk, M.M. (1998) A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Rheumatology 37, 1307-1314
25. Evans, C.H. and Stefanovic-Racic, M. (2000) Nitric oxide and inflammatory joint diseases. In Free Radicals and Inflammation (Winyard, P.G., Blake, D.R. and Evans, C.H., eds.), pp. 155-168, Birkhauser, Basel
26. Mapp, P.I., Klocke, R., Walsh, D.A., Chana, J.K., Stevens, C.R., Gallagher, P.J. and Blake, D.R. (2001) Localization of 3-nitrotyrosine to rheumatoid and normal synovium. Arthritis Rheum. 44, 1534-1539 (Pubitemid 32642215)
27. Cox, R.D. and Frank, C.W. (1982) Determination of nitrate and nitrite in blood and urine by chemiluminescence. J. Anal. Toxicol. 6, 148-152 (Pubitemid 12086249)
28. Farrell, A.J., Blake, D.R., Palmer, R.M. and Moncada, S. (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51, 1219-1222
29. Ueki, Y., Miyake, S., Tominaga, Y. and Eguchi, K. (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23, 230-236 (Pubitemid 26078379)
30. Lui, L., Hausiaden, A., Zeng, M., Que, L., Heitman, J. and Stamler, J.S. (2001) A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410, 490-494 (Pubitemid 32240051)
31. Hilliquin, P., Borderie, D., Hernvann, A., Menkes, C.J. and Ekindjian, O.G. (1997) Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum. 40, 1512-1517 (Pubitemid 27430964)
32. Winyard, P.G., Knight, I.A., Shaw, F.L., Rocks, S.A., Davies, C.A., Eggleton, P., Haigh, R., Whiteman, M. and Benjamin, N. (2008) Determination of S-nitrosothiols in biological and clinical samples using electron paramagnetic resonance spectrometry with spin trapping. Methods Enzymol. 441, 151-160
33. Pacher, P., Beckman, J.S. and Liaudet, L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424 (Pubitemid 46217686)
34. 2α in urine of rheumatic patients. Nitric Oxide 21, 210-215
35. Ohmori, H., Oka, M., Nishikawa, Y., Shigemitus, H., Takeuchi, M., Magari, M. and Kanayama, N. (2005) Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine. Immunol. Lett. 96, 47-54 (Pubitemid 39600759)
36. Birnboim, H.C., Lemay, A.M., Lam, D.K.Y., Goldstein, R. and Webb, J.R. (2003) Cutting edge: MHC Class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J. Immunol. 171, 528-532 (Pubitemid 36871356)
37. Gilchrist, M., Winyard, P.G. and Benjamin, N. (2010) Dietary nitrate: good or bad? Nitric Oxide 15, 104-109
38. Zhang, Z., Naughton, D., Winyard, P.G., Benjamin, N., Blake, D.R. and Symons, M.C. (1998) Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem. Biophys. Res. Commun. 249, 767-772 (Pubitemid 28441913)
39. Gladwin, M.T. and Schechter, A.N. (2004) NO contest: nitrite versus S-nitroso-hemoglobin. Circ. Res. 94, 851-855 (Pubitemid 38490059)
40. Lundberg, J.O., Carlström, M., Larsen, F.J. and Weitzberg, E (2011) Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc. Res. 89, 525-532
41. Kapil, V., Milsom, A.B., Okorie, M., Maleki-Toyserkani, S., Akram, F., Rehman, F., Arghandawi, S., Pearl, V., Benjamin, N., Loukogeorgakis, S. et al. (2010) Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 56, 274-281
42. Bailey, S.J., Winyard, P.G., vanhatalo, A., Blackwell, J.R., DiMenna, F.J., Wilkerson, D.P., Tarr, J., Benjamin, N. and Jones, A.M. (2009) Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J. Appl. Physiol. 107, 1144-1155
43. vanhatalo, A., Bailey, S.J., Blackwell, J.R., DiMenna, F.J., Pavey, T.G., Wilkerson, D.P., Benjamin, N., Winyard, P.G. and Jones, A.M. (2010) Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1121-R1131
44. Whiteman, M. and Winyard, P.G. (2011) Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev. Clin. Pharmacol. 4, 13-32
45. Whiteman, M. (2009) Is hydrogen sulfide a regulator of nitric oxide bioavailability in the vasculature? In Redox Signaling and Regulation in Biology and Medicine (Jacob, C. and Winyard, P.G., eds.), pp. 293-316, Wiley-VCH, Weinheim
46. Whiteman, M., Haigh, R., Tarr, J.M., Gooding, K.M., Shore, A.C. and Winyard, P.G. (2010) Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Ann. N.Y. Acad. Sci. 1203, 146-150
47. 2S signals through protein S-sulfhydration. Sci. Signaling 2, p. ra72
48. Eggleton, P., Haigh, R. and Winyard, P.G. (2008) The consequence of neo-antigenicity of the 'altered self'. Rheumatology 47, 567-571
49. Schellekens, G.A., De Jong, B.A., van Den Hoogen, F.H., van De Putte, L.B. and van Venrooij, W.J. (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273-281 (Pubitemid 28058927)
50. Nissim, A., Winyard, P.G., Corrigall, V., Fatah, R., Perrett, D., Panayi, G. and Chernajovsky, Y. (2005) Generation of neo-antigenic epitopes after the post-translational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum. 52, 3829-3838 (Pubitemid 41798221)
51. Ryan, B., Winyard, P.G., Viner, N., Haigh, R., Haas, M., Nissim, A, Isenberg, D. and Eggleton, P. (2009) Oxidative modifications to C1q increase the sensitivity of an anti-C1q ELISA in the diagnosis of systemic lupus erythematosus. Rheumatol. 48 (Suppl.), i2